Within3, a collaboration and communication service for the biotech and pharma industries, has raised over $100 million in new financing, the company said.
The investment came from Insight Partners with participation from Silversmith Capital Partners.
Most of the top 20 pharmaceutical companies already use the Lakewood, Ohio-based company’s service to publish clinical studies, host advisory boards and collaborate with researchers and other participants in the drug development process, according to a statement from the company.
Click here to read the complete story.
Story excerpt provided by TechCrunch.
Written by Jonathan Shieber.
Originally published September 24, 2020.